GSTM1 and anemia (phenotype): In conclusion, our findings suggest that the Hb/Cr ratio may represent a simple yet informative marker of increased risk in STEMI patients, capturing the combined burden of anemia and renal dysfunction—two conditions that, even when mild, appear to synergistically worsen prognoses.